STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

Turkish antitrust regulators are investigating Teva Pharmaceutical, the world’s largest generic drugmaker, for allegedly manipulating the patent system and making misleading statements to health care authorities about the safety and effectiveness of rival medicines.

The company engaged in “various practices… that may have been aimed at making it more difficult for competitors to enter the market,” according to Turkey’s Competition Board, which is known as Rekabet Kurumu and which launched the probe earlier this month but disclosed the decision last Friday on its website .